Data / Form D filings / Caladan Bio Inc.
Caladan Bio Inc.: Form D filing
Caladan Bio Inc., a technology company in New York, NY, filed a Form D with the SEC in 2024. The latest, on February 13, 2024, reports $5.1 million sold of a $5.1 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 27 W 16TH STREET UNIT 5D, New York, NY, 10011
- Phone
- (847) 370-1228
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2011857
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2024 | New notice | $5,110,000 | $5,110,000 | 7 | Feb 2, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael J. Kobida | Executive Officer, Director | |
| Robert J. Jauquet | Executive Officer, Director |
Other technology companies in New York that filed recently
- CreateOne Inc. $750,000 · Oct 30, 2026
- ShareWillow Compensation Inc. $4.7 million · Oct 30, 2026
- Portage Technologies Inc. $1.5 million · Oct 30, 2026
- Creeda, Inc. $175,000 · Oct 27, 2026
- Munee M & A, Inc. offering · Oct 27, 2026
- Halo Labs I LLC $84.9 million · Oct 26, 2026
Every Form D from the week of Feb 12, 2024 · All recent filings in New York · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Caladan Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.